Causal effect of air pollution on the risk of cardiovascular and metabolic diseases and potential mediation by gut microbiota

被引:12
|
作者
Liu, Chen -Xi [1 ]
Liu, Yu -Bo [1 ]
Peng, Yi [2 ]
Peng, Jia [1 ,3 ]
Ma, Qi-Lin [1 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Cardiovasc Med, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Rheumatol & Immunol TX, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Dept Cardiovasc Med, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
Air pollution; Particulate matter; Nitrogen oxides; Gut microbiota; Cardiovascular and metabolic diseases; Mendelian randomization; LONG-TERM EXPOSURE; FINE PARTICULATE MATTER; MENDELIAN RANDOMIZATION; INSULIN-RESISTANCE; R PACKAGE; HEALTH; PM2.5; OBESITY; COHORTS; BURDEN;
D O I
10.1016/j.scitotenv.2023.169418
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: Epidemiological studies have explored the relationship between air pollution and cardiovascular and metabolic diseases (CVMDs). Accumulating evidence has indicated that gut microbiota deeply affects the risk of CVMDs. However, the findings are controversial and the causality remains uncertain. To evaluate whether there is the causal association of four air pollutants with 19 CVMDs and the potential effect of gut microbiota on these relationships. Methods: Genetic instruments for particulate matter (PM) with aerodynamic diameter < 2.5 mu m (PM2.5), <10 mu m (PM10), PM2.5 absorbance, nitrogen oxides (NOx) and 211 gut microbiomes were screened. Univariable Mendelian randomization (UVMR) was used to estimate the causal effect of air pollutants on CVMDs in multiple MR methods. Additionally, to account for the phenotypic correlation among pollutant, the adjusted model was constructed using multivariable Mendelian randomization (MVMR) analysis to strength the reliability of the predicted associations. Finally, gut microbiome was assessed for the mediated effect on the associations of identified pollutants with CVMDs. Results: Causal relationships between NOx and angina, heart failure and hypercholesterolemia were observed in UVMR. After adjustment for air pollutants in MVMR models, the genetic correlations between PM2.5 and hypertension, type 2 diabetes mellitus (T2DM) and obesity remained significant and robust. In addition, genus-ruminococcaceae-UCG003 mediated 7.8 % of PM2.5-effect on T2DM. Conclusions: This study firstly provided the genetic evidence linking air pollution to CVMDs and gut microbiota may mediate the association of PM2.5 with T2DM. Our findings highlight the significance of air quality in CVMDs risks and suggest the potential of modulating intestinal microbiota as novel therapeutic targets between air pollution and CVMDs.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] The emerging role of gut microbiota in cardiovascular diseases
    Kumar, Dilip
    Mukherjee, Sanjeev S.
    Chakraborty, Rabin
    Roy, Rana Rathod
    Pandey, Arindam
    Patra, Soumya
    Dey, Somnath
    INDIAN HEART JOURNAL, 2021, 73 (03) : 264 - 272
  • [32] Gut microbiota and microbiota-derived metabolites in cardiovascular diseases
    Chen, Xiaofeng
    Zhang, Hua
    Ren, Sichong
    Ding, Yangnan
    Remex, Naznin Sultana
    Bhuiyan, Md. Shenuarin
    Qu, Jiahua
    Tang, Xiaoqiang
    CHINESE MEDICAL JOURNAL, 2023, 136 (19) : 2269 - 2284
  • [33] Gut Microbiota Composition in the Elderly with Metabolic Diseases
    Zhang, C. X.
    Karolina, M.
    Yang, Y. M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S350 - S350
  • [34] Assessing the Human Gut Microbiota in Metabolic Diseases
    Karlsson, Fredrik
    Tremaroli, Valentina
    Nielsen, Jens
    Backhed, Fredrik
    DIABETES, 2013, 62 (10) : 3341 - 3349
  • [35] Gut microbiota and metabolic diseases: myth or reality?
    Serino, Matteo
    Burcelin, Remy
    MEDITERRANEAN JOURNAL OF NUTRITION AND METABOLISM, 2011, 4 (01) : 75 - 77
  • [36] The gut microbiota: a key regulator of metabolic diseases
    Yang, Jin-Young
    Kweon, Mi-Na
    BMB REPORTS, 2016, 49 (10) : 536 - 541
  • [37] Interactions Between Therapeutics for Metabolic Disease, Cardiovascular Risk Factors, and Gut Microbiota
    Ding, Qi-You
    Tian, Jia-Xing
    Li, Min
    Lian, Feng-Mei
    Zhao, Lin-Hua
    Wei, Xiu-Xiu
    Han, Lin
    Zheng, Yu-Jiao
    Gao, Ze-Zheng
    Yang, Hao-Yu
    Fang, Xin-Yi
    Tong, Xiao-lin
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10
  • [38] Gut microbiota and microbiota-derived metabolites in cardiovascular diseases
    Chen Xiaofeng
    Zhang Hua
    Ren Sichong
    Ding Yangnan
    Remex Naznin Sultana
    Bhuiyan Md Shenuarin
    Qu Jiahua
    Tang Xiaoqiang
    中华医学杂志英文版, 2023, 136 (19)
  • [39] Physical exercise, gut, gut microbiota, and atherosclerotic cardiovascular diseases
    Jingyuan Chen
    Yuan Guo
    Yajun Gui
    Danyan Xu
    Lipids in Health and Disease, 17
  • [40] Physical exercise, gut, gut microbiota, and atherosclerotic cardiovascular diseases
    Chen, Jingyuan
    Guo, Yuan
    Gui, Yajun
    Xu, Danyan
    LIPIDS IN HEALTH AND DISEASE, 2018, 17